Molecularly, Cannabidivarin (CBDV) is extremely similar to CBD. When isolated from the cannabis plant, CBDV does not produce any intoxicating effects. CBDV is mostly found in cannabis strains that are high in CBD and low in THC. CBDV has been shown to work on the neurochemical part of the endocannabinoid system of the human body. This means that it has many therapeutic effects for those with neurological, mood, and inflammatory issues.
There has been a mass amount of research done on Cannabidivarin (CBDV) as it is a fairly major cannabinoid. Research has shown that CBDV could be helpful in treatment for muscle treatment, neurological functions, and nausea. In a study done by J Psychopharmacol in 2019, researchers found that Cannabidivarin assisted in the improvement of cognitive, motor, and neurological functions found in varying genetic disorders. Another study, studied and completed by Br J Pharacol in 2019, found that Cannabidivarin (CBDV) could potentially help improve muscle strength and quality, and help slow affects of muscle dystrophy.
Cannabidivarin (CBDV) has been researched most for its therapeutic properties relating to convulsions and epilepsy. CBDV has been found to bind to the CB1 and CB2 receptors, according to a study done in 2014 by Rosenthaler et al. In one of the studies done on Cannabidivarin in 2017, CBDV and CBD showed a huge potential to treat convulsions and epilepsy.
CBDV is most common in high CBD strains. Check some of them out below:
Euphoria (Indica) - aroma of sweet and fruity flavor
Medical Mass (Indica) - aroma of sweetness, honey, and skunkiness
Dance World (Sativa) - aroma of fruit, spices, and earth
Painkiller XL (Sativa) - aroma of diesel and lemon
Royal Medic (Sativa) - aroma of fruity and hash
Molar mass: 286.415 g·mol−1
Molecular weight: 286.41
If the research done on Cannabidivarin isn’t enough to wow you, check out its sister cannabinoid, CBD, to check out its therapeutic properties.